Clinical Trial: First-line treatment of recurrent / metastatic head and neck squamous cell carcinoma with paclitaxel polymer micelles for injection, cisplatin combined with immune checkpoint inhibitors : a single-arm (China)

China, Oct. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'First-line treatment of recurrent / metastatic head and neck squamous cell carcinoma with paclitaxel polymer micelles for injection, cisplatin combined with immune checkpoint inhibitors : a single-arm'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134839

Registration Time: 2026/10/21

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348599

Published by HT Digital Content Services with permission from Health Daily Digest....